Exeter University Spin‑out SENISCA Drives Next‑Gen Anti‑Ageing Research with L’Oréal Partnership
Post 0 Share 0 University of Exeter biotech spin-out is taking a bold step into the global longevity landscape. SENISCA, which emerged from nearly two decades of... Read more.
UK Government Commits £86bn to R&D with Life Sciences Key Priority
Post 0 Share 0 The UK government has committed £86 billion to research and development over the next four years, with life sciences identified as a strategic priority.... Read more.
Day in the Life: BioInformatics
Regional leaders in Greater Manchester and Liverpool City Region are working together to propose a new initiative aimed at improving the UK’s biotech and life... Read more.
North West Leaders Present Northern Arc Vision to Strengthen UK Biotech Connectivity
Post 0 Share 0 Regional leaders in Greater Manchester and Liverpool City Region are working together to propose a new initiative aimed at improving the UK’s biotech... Read more.
UK Government Unveils Over £1 Billion in Life Sciences Funding
The UK Government has announced a series of significant investments totaling over £1 billion to bolster the nation's life sciences sector. These initiatives aim... Read more.
Iksuda Begins First-in-Human Trial of CD19-Targeting ADC for B Cell Lymphoma
Newcastle-based Iksuda Therapeutics has announced a key clinical milestone with the dosing of the first patient in its Phase 1 trial of IKS03, a CD19-targeting antibody-drug... Read more.
Xyme Moves into Inventa as Oxford’s West End Innovation Cluster Gathers Pace
Post 0 Share 0 Xyme, a next-generation enzyme design company, has moved into the newly completed Inventa building at Oxford’s West End, taking up 5,600 sq ft of... Read more.
Gene Weaver Secures £405K Gates Foundation Grant to Advance Programmable Gene Insertion Platform
Cambridge-based biotech Gene Weaver has secured a $515,000 (approx. £405,000) grant from the Bill & Melinda Gates Foundation to progress its programmable gene... Read more.
Shift Bioscience Appoints Lord David Prior as Chair and Sir Tony Kouzarides as Scientific Advisor
Precision medicine innovator Closed Loop Medicine (CLM) appoints Kate Woolland as its new Chief Executive Officer, marking a significant leadership transition as... Read more.
Kate Woolland Appointed CEO of Closed Loop Medicine
Precision medicine innovator Closed Loop Medicine (CLM) appoints Kate Woolland as its new Chief Executive Officer, marking a significant leadership transition as... Read more.